{{Rsnum
|rsid=2241220
|Gene=ACACB
|Chromosome=12
|position=109237224
|Orientation=plus
|GMAF=0.2089
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ACACB
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 73.5 | 24.8 | 1.8
| HCB | 46.7 | 38.7 | 14.6
| JPT | 54.0 | 39.8 | 6.2
| YRI | 55.1 | 36.1 | 8.8
| ASW | 61.4 | 33.3 | 5.3
| CHB | 46.7 | 38.7 | 14.6
| CHD | 56.0 | 41.3 | 2.8
| GIH | 64.4 | 31.7 | 4.0
| LWK | 44.5 | 46.4 | 9.1
| MEX | 69.0 | 29.3 | 1.7
| MKK | 61.5 | 33.3 | 5.1
| TSI | 67.6 | 31.4 | 1.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19846279
|Title=Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels
|OA=1
}}

{{PMID|18031993}} Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}